This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

8 Stocks Under $10 to Avoid at All Costs

Live Nation Entertainment

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Live Nation Entertainment (LYV - Get Report) is involved in the promotion of live concerts, operates concert venues and sells tickets. Live Nation has lost money in 13 of the last 23 quarters and is expected to do so in the current quarter. The company seems to fare well only in fair-weather months. Has it heard about indoor arenas?

This is a very tough business, which is increasingly finding that live entertainment is more costly to operate, too expensive for consumers and has to contend with competition from modern digital technology and a operate in a less than robust economy. Consumers with the most purchasing power tend to be the baby boomers who seek out concerts to hear their favorite singers or bands from their youth but unfortunately those opportunities are diminishing over time. They would rather stay home and watch a concert on their 60 inch flat panel TV.

One big bet on Live Nation comes from Chase Coleman's Tiger Global Management, which increased its position in the stock by 31% to 15.7 million shares in the third quarter.

Cadence Pharmaceuticals

Cadence Pharmaceuticals (CADX) develops and markets an intravenous form of acetaminophen or APAP. Over the years, many companies have come and gone with the promise of developing and selling the next great painkiller. A hot stock several years ago was Penwest Pharmaceuticals, which never delivered to shareholders and wound up being purchased by Endo Pharmaceuticals (ENDP).

Cadence has virtually no revenue and has lost money for years. I do not see how this company will succeed where others have not. About the only positive is that Cadence has some cash on its balance sheet, but I am not certain that will last long as cash burn is very high. In fact, just last month, Cadence had to sell more stock in order to raise cash.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CADX $0.00 0.00%
DYN $31.15 0.87%
ELY $9.50 -1.00%
FSS $15.80 -1.40%
LYV $25.16 -0.36%


DOW 17,891.26 -85.05 -0.47%
S&P 500 2,077.99 -8.25 -0.40%
NASDAQ 4,924.65 -22.7910 -0.46%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs